Startseite

Aktien

Ardelyx

Nachrichten

Ardelyx Aktie

Aktie

ISIN: US0396971071 WKN: A116X0 SYM: ARDX Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

6,6500

USD

+6,91 %

+0,4300 USD

Letzter Kurs 02:00:00 Nasdaq

Ardelyx Aktie kaufen

Geldkurs

04.03.26

6,6400

USD

1.500 STK

Briefkurs

04.03.26

6,6500

USD

7.800 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Mo-Fr von 07:30 bis 23:00 Uhr
Neu: Samstag von 14:00 bis 19:00 Uhr

Neueste Nachrichten

Ardelyx to Participate in Upcoming Investor Conferences 04.03.26 · globenewswire · Ardelyx
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions 24.02.26 · globenewswire · Ardelyx
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update 19.02.26 · globenewswire · Ardelyx
Fokus Aktien mit extremen Handelsvolumen am Montag, den 16.02.2026 16.02.26 · wO Chartvergleich · TOYOTA TSUSHO CORPORATION
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 05.02.26 · globenewswire · Ardelyx
Ardelyx Receives New Patent for Tenapanor 03.02.26 · globenewswire · Ardelyx
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA 28.01.26 · globenewswire · Ardelyx
DAX, Corvus Pharmaceuticals & Co. – Tops & Flops der Community am Nachmittag 20.01.26 · Markt Bote · Eutelsat Communications
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook 08.01.26 · globenewswire · Ardelyx
Real-World Evidence Studies of XPHOZAH (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week 07.11.25 · globenewswire · Ardelyx
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London 05.11.25 · globenewswire · Ardelyx
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference 04.11.25 · globenewswire · Ardelyx

1
2
…
3

Ardelyx to Participate in Upcoming Investor Conferences 108 Leser

Fokus Aktien mit extremen Handelsvolumen am Montag, den 16.02.2026 580 Leser
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update 144 Leser
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues ... 124 Leser
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 116 Leser
Ardelyx to Participate in Upcoming Investor Conferences 108 Leser

DAX, Corvus Pharmaceuticals & Co. – Tops & Flops der Community am Nachmittag 1280 Leser
Fokus Aktien mit extremen Handelsvolumen am Freitag, den 31.10.2025 720 Leser
Fokus Aktien mit extremen Handelsvolumen am Montag, den 16.02.2026 580 Leser
Real-World Evidence Studies of XPHOZAH (tenapanor) Demonstrate Patient Satisfaction and Reduction ... 220 Leser
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind ... 208 Leser
Ardelyx Presents Data Supporting IBSRELA (tenapanor) at Digestive Disease Week 2025 Conference 188 Leser
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources ... 184 Leser
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook 176 Leser
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of ... 160 Leser
Ardelyx Announces Changes to the Executive Leadership Team 160 Leser